Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20,788,527
-
Total 13F shares
-
115,187,825
-
Share change
-
+13,530,153
-
Total reported value
-
$1,395,722,024
-
Put/Call ratio
-
43%
-
Price per share
-
$12.12
-
Number of holders
-
139
-
Value change
-
+$164,445,280
-
Number of buys
-
88
-
Number of sells
-
49
Institutional Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q1 2014
As of 31 Mar 2014,
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) was held by
139 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
115,187,825 shares.
The largest 10 holders included
OPPENHEIMER FUNDS INC, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, FEDERATED INVESTORS INC /PA/, BlackRock Fund Advisors, JPMORGAN CHASE & CO, FIRST TRUST ADVISORS LP, State Street Corp, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and BlackRock Institutional Trust Company, N.A..
This page lists
137
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.